RIDLEY US supplier risk profile: Q1 2026 trade data, compliance screening, China sourcing footprint analysis.
RIDLEY US imported 68 shipments in Q1 2026 across 2 suppliers, with 100% sourcing concentration in China. The importer's supply chain centers on two entities within the Inner Mongolia Eppen Biotech organization, with the larger subsidiary accounting for 63 shipments. No HS codes were reported in the dataset, preventing commodity-level analysis of the import profile.
Trigram screen against OFAC SDN, BIS Entity List, UFLPA Entity List, SAM Exclusions, EU FSF, UK HMT, UN SC, and 25+ allied jurisdictions.
Distance-screened against all 380 facilities in the ASPI Xinjiang Data Project. Proximity score: 100 / 100.
RIDLEY US registered zero matches against sanctions watchlists in Q1 2026. No suppliers in the identified supply chain showed proximity to UFLPA forced-labor exposure at this reporting level.
2 distinct tier-1 suppliers in Q1 2026
| INNER MONGOLIA EPPEN BIOTECH L | China | 63 |
| INNER MONGOLIA EPPEN BIOTECH LT | China | 5 |
Share of Q1 2026 inbound shipments by source country
1 tier-2 + 4 tier-3 nodes mapped - sign up to see them.
Free Tarifflo account unlocks the complete tier 1 / 2 / 3 supplier graph, daily refresh, alerts, and sanctions + UFLPA monitoring on every shipment.